Johnson & Johnson announces agreement with US Government for 100 million doses of investigational COVID-19 vaccine
On Aug. 5, 2020, Johnson & Johnson announced a $1 billion agreement with the U.S. government for the…
-
-
Pfizer and BioNTech to supply Canada with their BNT162 mRNA- based vaccine candidate
On Aug. 5, 2020, Pfizer Canada and BioNTech SE today announced an agreement with the Government of Canada…
-
VBI Vaccines awarded up to CAD$56 million contribution from Canadian Government to accelerate Coronavirus vaccine development
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…
-
HKUMed researchers first discovered SARS-CoV-2 infects human neural progenitor cells and brain organoids
On Aug. 4, 2020, researchers at The University of Hong Kong (HKUMed) collaborated with researchers at the Institute…
-
Innovation Pharma and US Regional Biocontainment Laboratory updated brilacidin anti-SARS-CoV-2 in vitro testing
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
-
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
-
La Jolla Institute for Immunology received $1 million from GHR Foundation in support of COVID-19 research
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
-
Lilly initiated phase 3 trial of LY-CoV555 for prevention of COVID-19 at Long-term care facilities in partnership with NIAID
On Aug. 3, 2020, Eli Lilly announced the initiation of BLAZE-2, a phase 3 trial studying LY-CoV555 for…
-
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
-
Serum Institute of India received approval to start human trials for Oxford vaccine
On Aug. 1, 2020, the Serum Institute of India (SII) got the approval to start human trials in…
-
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the National Institutes of Health (NIH) to support…
-
Sanofi and GSK announced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
-
Sanofi and GSK selected for Operation Warp Speed to supply US government with 100 million doses of COVID-19 vaccine
On Jul. 31, 2020, Sanofi and GSK announced a collaborative effort with the U.S. government to accelerate the…
-
Biotechnology | COVID-19 | FDA
Precipio announced commercial launch of Covid-19 antibody test
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
-
Tyson Foods launched nationwide COVID monitoring strategy and expanded health staff
On Jul. 30, 2020, Tyson Foods announced that it had launched a new, industry-leading monitoring program and expanding…
-
BD announced $24 million US Government investment to support scale up of US manufacturing of COVID-19 diagnosic tests
On Jul. 30, 2020, BD (Becton, Dickinson) announced a $24 million investment from the U.S. Department of Defense…
-
Intravacc and Celonic to develop and produce a novel COVID-19 vaccine
On Jul. 29, 2020, Intravacc and Celonic Group, a biopharmaceutical contract development and manufacturing organization (CDMO), announced that…
-
PharmaCyte Biotech received CE Mark for licensed COVID-19 molecular tests
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
-
Veracyte and MAVIDx announcd agreement for MAVIDx to develop ultra-high volume COVID-19 testing on the nCounter System
On Jul. 29, 2020, Veracyte and MAVIDx announced an agreement for MAVIDx to develop ultra-high throughput genomic testing…
-
Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
-
FDA authorized Quest Diagnostics lab method designed to increase COVID-19 molecular diagnostics capacity
On Jul. 29, 2020, Quest Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
Sanofi and GSK agreed with the UK government to supply up to 60 million doses of COVID-19 vaccine
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
-
Experimental COVID-19 vaccine protected upper and lower airways in nonhuman primates
On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses…
-
Gilead Sciences and Satcher Health Leadership Institute partnered to study racial health inequities associated with COVID-19
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
-
StartX Med Alliance of Remote and Telehealth companies respond to shift in patient care during COVID-19 crisis
On Jul. 28, 2020, StartX announced the launch of its StartX Med Alliance of Remote and Telehealth (SMART)…
-
Immune system variation can predict severe COVID-19 outcomes
On Jul. 27, 2020, Yale university researchers reported that differing immune system responses of patients with COVID-19 can…
-
Emergent BioSolutions signed agreement with AstraZeneca to expand manufacturing for COVID-19 Vaccine candidate
On Jul. 27, 2020, Emergent BioSolutions announced that it had signed an agreement to provide contract development and…
-
Todos Medical announced SARS-nCoV-19 testing kit contract with NJ-based best supply clinical laboratory
On Jul. 27, 2020, Todos Medical announced the Company has entered into a contract to supply NJ-based laboratory…
-
LabCorp received authorization for COVID-19 sample pooling
On Jul. 25, 2020, LabCorp announced it received an Emergency Use Authorization from the FDA permitting diagnostic testing…
